Haemonetics stock forecast
Haemonetics (HAZ) Stock Forecast & Price Target
HAZ Analyst Ratings
HAZ Stock 12 Month Forecast
Average Price Target
€131.75▲(20.87% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Young Li | Jefferies | €135.59 | buy | 24.39%Upside | Initiated | 11/13/26 | ||
| Allen Gong | J.P. Morgan | €112.99 | hold | 3.66%Upside | Reiterated | 11/09/26 | ||
| David Rescott | Robert W. Baird | €128.36→€149.15 | buy | 36.83%Upside | Reiterated | 11/06/26 | ||
| Joanne Wuensch | Citi | €111.18→€134.69 | buy | 23.56%Upside | Reiterated | 11/06/26 | ||
| Anthony Petrone | Mizuho Securities | €126.55→€149.15 | buy | 36.83%Upside | Reiterated | 11/06/26 | ||
| Michael Petusky | Barrington | €126.55→€131.07 | buy | 20.25%Upside | Reiterated | 11/06/26 | ||
| Travis Steed | Bank of America Securities | ― | buy | ― | Reiterated | 11/06/26 | ||
| Marie Thibault | BTIG | €117.51→€128.36 | buy | 17.76%Upside | Reiterated | 11/05/26 | ||
| Michael Matson | Needham | ― | hold | ― | Reiterated | 10/21/26 | ||
| Andrew Cooper | Raymond James | €94.91→€112.99 | buy | 3.66%Upside | Reiterated | 09/03/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Young LiJefferies | BuyInitiated€135.59 | 11/13/26 | 24.39%Upside | ||
| Allen GongJ.P. Morgan | HoldReiterated€112.99 | 11/09/26 | 3.66%Upside | ||
| David RescottRobert W. Baird | BuyReiterated€128.36→€149.15 | 11/06/26 | 36.83%Upside | ||
| Joanne WuenschCiti | BuyReiterated€111.18→€134.69 | 11/06/26 | 23.56%Upside | ||
| Anthony PetroneMizuho Securities | BuyReiterated€126.55→€149.15 | 11/06/26 | 36.83%Upside | ||
| Michael PetuskyBarrington | BuyReiterated€126.55→€131.07 | 11/06/26 | 20.25%Upside | ||
| Travis SteedBank of America Securities | BuyReiterated | 11/06/26 | ― | ||
| Marie ThibaultBTIG | BuyReiterated€117.51→€128.36 | 11/05/26 | 17.76%Upside | ||
| Michael MatsonNeedham | HoldReiterated | 10/21/26 | ― | ||
| Andrew CooperRaymond James | BuyReiterated€94.91→€112.99 | 09/03/26 | 3.66%Upside |
Best Analysts Covering Haemonetics
Copying Andrew Cooper's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +12.75% per trade.
Copying Andrew Cooper's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +25.28% per trade.
Copying Andrew Cooper's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +53.08% per trade.
HAZ Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 9 | 15 | 13 | 17 | 16 |
| Hold | 4 | 6 | 6 | 6 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 21 | 19 | 23 | 18 |
In the current month, HAZ has received 16 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. HAZ average Analyst price target in the past 3 months is 131.75.
HAZ Financial Forecast
HAZ Earnings Forecast
Next quarter’s earnings estimate for HAZ is EUR 1.15 with a range of EUR 1.05 to EUR 1.29. The previous quarter’s EPS was EUR 1.22. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HAZ Sales Forecast
Next quarter’s sales forecast for HAZ is EUR 323.47M with a range of EUR 317.93M to EUR 331.38M. The previous quarter’s sales results were EUR 323.39M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

